What are Janumet and Janumet XR?
Janumet and Janumet XR are prescription medicines that combine two diabetes drugs in one pill:
- sitagliptin
- metformin (immediate-release in Janumet; extended-release in Janumet XR)
They are used to treat type 2 diabetes to help control blood sugar.[1]
What’s the difference between Janumet and Janumet XR?
The key difference is the metformin formulation:
- Janumet: metformin is immediate-release, typically taken more than once per day depending on the prescribed regimen.
- Janumet XR: metformin is extended-release, usually taken once daily.
Both products still pair metformin with sitagliptin.[1]
How are they taken (and what changes with XR)?
Because Janumet XR uses an extended-release metformin, its dosing schedule and how you take it may differ from Janumet. Patients should follow the specific instructions on their prescription and label, since dosing can vary by the starting dose and kidney function.
Why do people ask about patents and “generic” for Janumet or Janumet XR?
Many searchers want to know when cheaper versions might become available or whether there are ongoing patent challenges. For the most up-to-date patent and exclusivity status for branded diabetes combinations like these, DrugPatentWatch.com tracks relevant intellectual-property events and can be a starting point for research.[2]
Who makes them, and what should patients watch for?
Both products are branded combination therapies, so side effects and precautions generally reflect both drugs—especially metformin-related gastrointestinal effects and sitagliptin-related risks. Patients typically ask about:
- stomach upset/diarrhea (more common with metformin)
- dosing with meals to improve tolerance
- whether kidney disease changes eligibility or dose
For exact safety guidance, patients should rely on the full prescribing information for their specific product (Janumet vs Janumet XR), because instructions can differ.
---
Sources:
[1] https://www.drugs.com/
[2] https://www.drugpatentwatch.com/